LDR Brachytherapy: A minimally invasive curative treatment with excellent oncological and functional
The Central European Journal of Urology (CEJU) published a study in September 2018 titled: Low-dose-rate brachytherapy as a minimally invasive curative treatment for localised prostate cancer has excellent oncological and functional outcomes: a retrospective analysis from a single centre.
Prostate cancer is the second most commonly diagnosed cancer in men but research* shows that only half of men treated are fully aware of all of the treatment options available to them. The CEJU study explores brachytherapy as a viable option in the treatment of prostate cancer. The study analysed the oncological and functional outcomes in patients after being treated with brachytherapy for localised prostate cancer.
The study observed 201 patients who underwent brachytherapy between April 200